InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by van Houte Hans, Chief Financial Officer. Director active across 1 companies, notably Nurix Therapeutics, Inc.. In total, 4 filings have been recorded. The latest transaction was disclosed on 30 October 2025 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
02,886 shares0
Common Stock
SEC:0001817217-25-000003·
02,886 shares0
Common Stock
SEC:0001817217-25-000003:0·
€53,47468,333 shares@ €0.78260.0030% mcap100.0% of flow
Common Stock
SEC:0001209191-22-033200:0·
02,886 shares0
Common Stock
SEC:0001209191-22-026890:0·
4 of 4 declarations
About van Houte Hans
Hans van Houte is the Chief Financial Officer at Nurix Therapeutics, Inc. He is responsible for financial management and strategy for the company. His financial expertise is crucial for supporting Nurix's growth and sustainability.
